Sitafloxacin

CAT:
804-HY-B0395-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Sitafloxacin - image 1

Sitafloxacin

  • Description :

    Sitafloxacin (DU6859a) is a potent, orally active fluoroquinolone antibiotic. Sitafloxacin shows antichlamydial activity and antibacterial activities against a broad range of gram-positive and gram-negative bacteria, including anaerobic bacteria, as well as against atypical pathogens. Sitafloxacin can be used for the research of respiratory tract infection and urinary tract infection[1][2].
  • Product Name Alternative :

    DU6859a
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302, H315, H319, H335
  • Target :

    Antibiotic; Bacterial
  • Type :

    Reference compound
  • Related Pathways :

    Anti-infection
  • Applications :

    COVID-19-immunoregulation
  • Field of Research :

    Infection
  • Assay Protocol :

    https://www.medchemexpress.com/sitafloxacin.html
  • Purity :

    99.37
  • Solubility :

    10 mM in DMSO
  • Smiles :

    O=C(C1=CN([C@H]2[C@@H](F)C2)C3=C(C=C(F)C(N(C[C@H]4N)CC54CC5)=C3Cl)C1=O)O
  • Molecular Formula :

    C19H18ClF2N3O3
  • Molecular Weight :

    409.81
  • Precautions :

    H302, H315, H319, H335
  • References & Citations :

    [1]Okumura R, et al. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae. J Antimicrob Chemother. 2008 Jul;62 (1) :98-104.|[2]Dhople AM, et al. Activities of sitafloxacin (DU-6859a), either singly or in combination with rifampin, against Mycobacterium ulcerans infection in mice. J Chemother. 2003 Feb;15 (1) :47-52.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Launched
  • Isoform :

    Quinolone
  • Citation 01 :

    Antimicrob Resist Infect Control. 2019 Feb 15:8:40.|Curr Microbiol. 2021 Dec 14;79 (1) :12.|Infect Drug Resist. 2019 Jan 31:12:345-358.|PLoS One. 2019 Mar 27;14 (3) :e0213868.|bioRxiv. 2024 Nov 06.
  • CAS Number :

    [127254-12-0]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide